Touyun Biotech Group's (HKG:1332) subsidiary Shanxi Touyun Biotechnology was permitted by the National Health Commission to expand the scope of its product, Chlamydomonas reinhardtii.
Chlamydomonas reinhardtii can now enter the markets of vegan fish, shrimp, and plant-based milk, a Wednesday Hong Kong bourse filing said.